Evidence map›Paper›PMID 28321419›Full record

ArticleJournal of immunology research2017

pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity.

Sofia Fernanda Gonçalves Zorzella-Pezavento, Fernanda Chiuso-Minicucci, Thais Graziela Donegá França, Larissa Lumi Watanabe Ishikawa, Larissa Camargo da Rosa, Priscila Maria Colavite, Bianca Balbino, Camila Marques, Maura Rosane Valerio Ikoma, Ana Paula Masson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Peptide-Based Vaccination Therapy for Rheumatic Diseases.Journal of immunology research · 2020
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sofia Fernanda Gonçalves Zorzella-PezaventoDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0001-9030-0768
Fernanda Chiuso-MinicucciDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.
Thais Graziela Donegá FrançaDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0001-8307-1311
Larissa Lumi Watanabe IshikawaDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0003-3481-2181
Larissa Camargo da RosaDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0002-4849-8835
Priscila Maria ColaviteDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0002-1619-6728
Bianca BalbinoDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0002-0676-3012
Camila MarquesFlow Cytometry Laboratory, Amaral Carvalho Foundation, Jaú, SP, Brazil.
Maura Rosane Valerio IkomaFlow Cytometry Laboratory, Amaral Carvalho Foundation, Jaú, SP, Brazil.
Ana Paula MassonDepartment of Biochemistry and Immunology, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.
Célio Lopes SilvaDepartment of Biochemistry and Immunology, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.
Alexandrina SartoriDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.ORCID 0000-0003-4557-3331
Universidade Estadual Paulista (Unesp) · BRHospital Amaral Carvalho · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a demyelinating pathology of the central nervous system (CNS) used as a model to study multiple sclerosis immunopathology. EAE has also been extensively employed to evaluate potentially therapeutic schemes. Considering the presence of an immune response directed to heat shock proteins (hsps) in autoimmune diseases and the immunoregulatory potential of these molecules, we evaluated the effect of a previous immunization with a genetic vaccine containing the mycobacterial hsp65 gene on EAE development. C57BL/6 mice were immunized with 4 pVAXhsp65 doses and 14 days later were submitted to EAE induction by immunization with myelin oligodendrocyte glycoprotein (MOG

Indexed as

AnimalsBacterial ProteinsChaperonin 60Cloning, MolecularEncephalomyelitis, Autoimmune, ExperimentalFemaleForkhead Transcription FactorsHumansMiceMice, Inbred C57BLMultiple SclerosisMyelin-Oligodendrocyte GlycoproteinMyelitisPeptide FragmentsT-Lymphocytes, RegulatoryVaccinationBacterial ProteinsChaperonin 60Forkhead Transcription FactorsFoxp3 protein, mouseheat-shock protein 65, MycobacteriumMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsVaccines, DNA

Identifiers

PMID28321419
PMCPMC5339488
OpenAlexW2589983434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.